Received Mar 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | — | — |
Pharmacist inquiring if a 45-year-old patient with low titers can receive a booster of MMRII.; This spontaneous report was received from a pharmacist and refers to a 45-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (dose, vaccination site, route of administration, lot # and expiration date were not reported) administered for prophylaxis. The vaccine was reconstituted with sterile diluent, solution for injection. On an unknown date, the patient had low titers (antibody test negative). The pharmacist was inquiring if a 45-year-old patient with low titers can receive a booster of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II). The caller stated that the patient would like a booster shot. It was unknown if the dose was administered. No additional information was provided. No additional adverse event (AE) and no product quality complaint (PQC) was reported. At the reporting time, the outcome of the adverse event was not provided. The causal relationship between the adverse event and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was not reported. Lot # is being requested and will be submitted if received.
Sterile diluent
Test Name: Titers; Result Unstructured Data: low titers